"三医"协同稳健推进，医疗医保良性互动。青海以系统改革破解深层次问题，稳步推进医疗服务价格调 整，累计执行价格项目8163项，医疗服务收入占比提升至36.64%，超过全国平均水平。医保支付方式 改革深入推进，建立激励约束机制，引导医疗机构回归公益定位、提升服务内涵。通过建立医保预付金 制度，有效缓解公立医院资金压力。改革促使全省医疗次均费用和平均住院床日较2021年显著下降，实 现了医疗机构管理水平和基金使用绩效的双提升。 便民服务智能精细，群众办事省心便捷。以"高效办成一件事"为目标，青海"智慧医保"建设提速。医保 码激活使用率在全国率先实现全覆盖，"刷脸"结算基本覆盖定点医药机构。政务服务事项线上可办率超 95%，同时依托基层组织和银行网点等，实现医保服务站点乡镇、村社全覆盖，并探索建立流动服务 队，将服务延伸到群众"门口"。异地就医直接结算拓宽至全国所有定点医药机构，"一站式"结算、跨省 协同（如与川、甘、藏等地对接）让群众切实感受到"看病不用带卡、报销不用跑腿"的便利。 待遇保障持续夯实，群众获得感实实在在。全省基本医保参保扩面成效显著，2025年参保任务完成率达 100.69%，连续三年超额完成国家 ...

国际医学回复：您好，感谢您对公司的关注。中央经济工作会议对2026年医疗健康领域"三医协同"、药 品集采优化及医保支付方式改革的深化部署，体现了国家推动行业高质量发展的坚定决心，这对所有医 疗机构都提出了更高要求，也蕴含着新的发展机遇。面对行业政策的持续深化，公司将坚持发展战略目 标，以稳健经营为基础，强化成本管控和效率提升；以提升医疗质量和服务体验为核心，加强学科建 设，不断优化患者服务体系；以差异化策略构建竞争优势，增强服务附加值；积极适应行业变革，实现 服务规模的有序扩张、运营效率的持续优化、经营业绩的改善提升。谢谢! 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，国际医学(000516)12月29日在投资者关系平台上答复投资者关心的问题。 投资者提问：中央经济会议已经开完了，26年针对三医协同，优化药品集中采购，深化医保支付方式改 革，贵公司明年日子可能会更苦，不知道贵司能不能撑的住？ ...

《行动计划》明确了从起步、提速到全面实施的阶段性推进路径。这种分阶段、按步骤的推进方式，既 兼顾地方实际差异，又注重落地可操作性，确保改革稳步有序开展。尤其值得关注的是，将大病保险资 金、医疗救助基金纳入清算提速范围，更是对弱势群体、重症患者医疗资金迫切需求的精准回应，彰显 了对生命健康的切实关切。 提速更需要"提质"。根据《行动计划》，自2028年起，将实现每年3月底前完成上年度清算，清算资金 占年度医保基金拨付的3%左右，推进季度清算等创新模式。季度清算就像把"年终大考"变成"单元测 验"，推动医院从事后补救转向事中控制。智能化监管、标准化流程、风险防控体系建设必须同步跟 进，防止在提速过程中出现管理漏洞。《行动计划》还强调省级医保部门要总结试点经验，巩固清算成 果，规范全省清算流程，指导改革全面推进。可以说，确保清算提速与监管协同并进，才能让好政策取 得好效果。 每一笔异地就医直接结算数据的背后，都有一个求医问药的故事。"十五五"规划建议提出，"健全医 疗、医保、医药协同发展和治理机制"。医保清算提速的"一小步"，也是"三医协同"的"一大步"。脚踏 实地走好每一步，向着医保"全国漫游"前进。（中国经济网 ...

据悉，老来健康作为深耕慢病管理的数字健康平台，已服务超3400万名用户，对接10个省医保门特慢病 监管服务系统，覆盖全国超2亿名老人。此次"肾小保"SaaS软件的成功研发，是老来健康在三医协同领 域的重要突破，未来公司将持续迭代技术与服务，为更多医疗机构提供合规、高效、智能的数字化管理 解决方案，助力我国慢病管理体系高质量发展。 "'肾小保'最核心的价值，在于通过SaaS架构打破了医保、医疗、患者之间的信息壁垒，构建起'政策引 导—临床实施—患者参与'的三医协同闭环。"邵阳市中心医院负责人表示，自2025年10月份项目启动以 来，该SaaS软件已成功纳管159名腹透患者，患者满意度大幅提升，医院肾脏病管理的资源配置效率和 诊疗质量实现双重突破，为慢病管理提供了可复制、可推广的实践样本。 业内人士认为，老来健康"肾小保"以SaaS模式落地三医协同，具备三大推广优势：一是轻量化部署，降 低医疗机构数字化转型成本；二是数据实时协同，实现医保、医疗、患者三方信息互通；三是模式可扩 展性强，未来可从肾脏病管理延伸至糖尿病、高血压等更多慢病领域。该模式的成功推广，将为"十五 五"期间医疗保障智能化升级提供重要支撑。 本报 ...

工信部印发《产业技术基础公共服务平台管理办法》 近日，工业和信息化部印发新修订的《产业技术基础公共服务平台管理办法》，包括总则、申报、审核 发布、运行、动态管理、附则等6章22项条款，自2025年12月5日起施行。《管理办法》提出，服务平台 申报单位应当明确申报的服务行业领域及服务范围。服务平台应加强自身能力建设，不断提高业务能 力、服务开放水平，结合发展实际提升数据开源共享水平，密切关注产业发展动态和技术趋势，探索新 业务模式和商业模式，及时调整、优化服务内容，强化数据应用效能，提高服务质量和服务效率，赋能 企业发展。（来源：工业和信息化部） 日前，面向哲学社会科学领域的人工智能大模型在湖北武汉正式上线。这套由湖北省社科联牵头打造 的"湖北社会科学AI模型及其应用服务项目"，不仅搭载了国产、安全、可控的智能底座，更同步推出了 全国首台社科智能交互机器人"荆哲"，并组建了首批"数智社科专家"团队。此举标志着湖北在推动"社 科+AI"深度融合、构建数智化社科普及新体系上迈出关键一步。 内蒙古地质矿产集团AI找矿预测获突破 构建全区首个找矿大模型专用数据集 12月9日，内蒙古地质矿产集团召开AI找矿预测成果汇报会 ...

新华社北京12月3日电 题：健全多层次医疗保障体系 筑牢民生保障底线——访国家医保局局长章 轲 新华社记者彭韵佳 医保，关系每个参保人的切身利益。党的二十届四中全会审议通过的《中共中央关于制定国民经济 和社会发展第十五个五年规划的建议》（以下简称《建议》），提出"健全多层次医疗保障体系""推进 基本医疗保险省级统筹"等系列部署。 如何健全多层次医疗保障体系？如何让医保改革成果更好惠及群众健康？新华社记者专访了国家医 保局局长章轲。 破解看病难、看病贵问题取得突破性进展 问："十四五"时期，医疗保障制度改革如何提升百姓获得感？ 答：党的十八大以来，全民医疗保障制度改革持续推进，参保质量明显提升，人民群众医保获得感 显著提高。 国家医保局持续推进"1+3+N"多层次医疗保障体系建设，基本医保、大病保险、医疗救助三重基本 医疗保障制度进一步巩固提升。职工医保、居民医保政策范围内住院费用报销比例分别达到80%和70% 左右，普遍开展普通门诊统筹和门诊慢性病、特殊疾病保障，减轻参保人员门诊医疗费用负担。大病保 险进一步减负，城乡居民大病保险保障水平在基本医保基础上提高10到15个百分点。健全统一规范的医 疗救助制度。 ...

原标题：贯彻落实党的二十届四中全会精神权威访谈|健全多层次医疗保障体系 筑牢民生保障底线—— 访国家医保局局长章轲 新华社北京12月3日电（新华社记者 彭韵佳）医保，关系每个参保人的切身利益。党的二十届四中全会 审议通过的《中共中央关于制定国民经济和社会发展第十五个五年规划的建议》（以下简称《建 议》），提出"健全多层次医疗保障体系""推进基本医疗保险省级统筹"等系列部署。 如何健全多层次医疗保障体系？如何让医保改革成果更好惠及群众健康？新华社记者专访了国家医保局 局长章轲。 破解看病难、看病贵问题取得突破性进展 国家医保局持续推进"1+3+N"多层次医疗保障体系建设，基本医保、大病保险、医疗救助三重基本医疗 保障制度进一步巩固提升。职工医保、居民医保政策范围内住院费用报销比例分别达到80%和70%左 右，普遍开展普通门诊统筹和门诊慢性病、特殊疾病保障，减轻参保人员门诊医疗费用负担。大病保险 进一步减负，城乡居民大病保险保障水平在基本医保基础上提高10到15个百分点。健全统一规范的医疗 救助制度。 以"减负、提质、便民"为导向，多举措强化保障实效。"十四五"期间，医保基金累计支出超13万亿元， 惠及近200亿 ...

Core Points - The Beijing Tongrentang's second community health service center in Huaxiang Street officially commenced operations, enhancing local healthcare services for thousands of residents [1][2] - The center features a comprehensive service system that integrates general and specialized care with traditional Chinese medicine, aiming to provide convenient and efficient medical services [2][3] - The center's unique "famous doctors + famous medicines" dual assurance system leverages high-quality traditional Chinese medicine and expert practitioners to ensure effective healthcare delivery [3][4] Summary by Sections Service Features - The health service center includes 14 clinical departments and various medical technology support services, offering a wide range of treatments and preventive care [2][3] - Services include traditional Chinese medicine techniques such as acupuncture and cupping, alongside modern medical practices, ensuring comprehensive healthcare coverage [2][3] Community Impact - The center is positioned as a reliable "health station" for residents, providing accessible healthcare and promoting public health in the Huaxiang area [3][4] - The opening of the center is seen as a significant step towards enhancing public health capabilities in the region, contributing to the "Healthy Fengtai" initiative [2][4] Strategic Development - Beijing Tongrentang is expanding its community healthcare network, having already established services in multiple districts, serving nearly 300,000 residents [4][5] - The company is committed to integrating online and offline healthcare services, enhancing accessibility through digital platforms [4][5] Tailored Services - The center offers customized services for different demographics, including elderly care packages and home visits for those with mobility issues, ensuring comprehensive support for all community members [5] - The focus on "Chinese medicine +" highlights the company's commitment to providing culturally relevant healthcare solutions [5]

Core Insights - The 13th Health Industry Hospital Management Conference was held in Hainan, where a strategic cooperation agreement was signed among the Hainan Boao Lecheng International Medical Tourism Pilot Zone Administration, Qionghai Municipal Government, and WeDoctor Holdings [1][3] Group 1: Strategic Cooperation - The three parties will collaborate on the construction of the "Lecheng International Medical Alliance" and the "Qionghai Digital Health Community," aiming to create a top-tier medical resource "super interface" that serves Hainan's free trade port and extends nationwide and globally [3][5] - The establishment of the "Lecheng International Innovative Drug and Medical Device Medical Alliance" was announced during the conference, with the first batch of 10 cooperative hospitals signing agreements on-site [3][4] Group 2: Innovative Medical Services - The Lecheng Medical Alliance will leverage telemedicine platforms to facilitate a digital closed-loop service for patients, transforming the traditional lengthy process of drug approval and patient care into a more efficient and accessible system [3][4] - A case study was presented where a patient with a chronic condition received innovative treatment recommendations through the Lecheng Medical Alliance platform, showcasing the platform's potential impact on patient care [4] Group 3: Future Developments - The Lecheng Medical Alliance aims to promote a collaborative model where patients are treated locally, with follow-ups and data sharing, enhancing the overall healthcare experience [4][5] - WeDoctor Holdings plans to utilize its advanced digital technology and platform resources to support the development of Lecheng as a "health portal" for patients across China, ensuring quicker access to global medical innovations [5][6] - The strategic cooperation will also focus on exploring reforms in medical insurance payment methods and improving the efficiency of regional medical institutions, contributing to the development of a "Healthy Qionghai" [5]

Core Insights - The article discusses the strategic opportunities in China's pharmaceutical sector as it transitions from the "14th Five-Year Plan" to the "15th Five-Year Plan," emphasizing the integration of health initiatives and global biopharmaceutical competition [1][2] Industry Development - The "15th Five-Year Plan" outlines a health-first development strategy, focusing on enhancing public health capabilities, promoting hierarchical diagnosis and treatment, and supporting the development of innovative drugs and medical devices [2][3] - The plan aims to bind pharmaceutical industry upgrades with national economic structure optimization, driving high-quality industry development [2][3] Innovation in Pharmaceuticals - During the "14th Five-Year Plan," China approved 210 innovative drugs and 269 innovative medical devices, with the biopharmaceutical market becoming the second largest globally, accounting for approximately 30% of global innovative drugs in development [1][2] - The approval of innovative drugs has accelerated, with 43 drugs approved in the first half of 2024, marking a 59% year-on-year increase [5][6] Medical Device Sector - From 2014 to 2024, 315 innovative medical devices were approved, with 65 approved in 2024 alone, indicating a sustained high level of approvals [6][7] - The government has introduced measures to support the development of high-end medical devices, including optimizing approval processes and enhancing regulatory frameworks [6][7] Public Health and Disease Control - The article highlights the importance of strengthening public health capabilities and disease control systems, particularly in managing major infectious and chronic diseases [9][10] - The "15th Five-Year Plan" emphasizes the need for a comprehensive approach to disease prevention and control, integrating various health services [9][10] Challenges and Recommendations - Experts suggest increasing funding for innovative drug research and improving the investment environment for pharmaceutical companies [7][8] - The need for enhanced collaboration between healthcare, insurance, and pharmaceutical sectors is emphasized to create a more efficient healthcare delivery system [3][4]